Literature DB >> 9405335

The p130 pocket protein: keeping order at cell cycle exit/re-entrance transitions.

X Mayol1, X Grana.   

Abstract

Pocket proteins, including the retinoblastoma susceptibility gene product (pRB) and the related proteins p107 and p130, function at cell cycle regulatory steps that link cyclin/CDK-integrated positive and negative growth signals with E2F transcription factor activity on genes required for cell cycle progression. Protein complex formation between pocket proteins and members of the E2F family of transcription factors determines whether E2F complexes act as transcriptional activators or repressors. Experimental work over the last few years indicates that individual pocket proteins interact with specific E2F members to regulate the transcription of certain genes under diverse cell growth conditions. Among these protein associations, p130-containing E2F complexes seem to be of particular importance in controlling gene transcription in quiescent and differentiating cells by repressing the transcription of a set of E2F-responsive genes. Once the cells are progressing through the G1 phase of the cell cycle, pocket protein-mediated regulation of E2F activity is assumed by pRB and p107. p130-mediated transcriptional regulation thus seems to prevent a gene expression program characteristic of dividing cells at the cell cycle exit and re-entrance transitions and in quiescent cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9405335     DOI: 10.2741/a263

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  12 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

2.  E1A blocks hyperphosphorylation of p130 and p107 without affecting the phosphorylation status of the retinoblastoma protein.

Authors:  M Parreño; J Garriga; A Limón; X Mayol; G R Beck; E Moran; X Graña
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.

Authors:  Yi Cao; Zhefeng Zhao; Joanna Gruszczynska-Biegala; Anna Zolkiewska
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

4.  Nucleocytoplasmic shuttling of p130/RBL2: novel regulatory mechanism.

Authors:  Anton Chestukhin; Larisa Litovchick; Katherine Rudich; James A DeCaprio
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

5.  Induction of Wnt/β-catenin signaling in mouse mesenchymal stem cells is associated with activation of the p130 and E2f4 and formation of the p130/Gsk3β/β-catenin complex.

Authors:  Nikolay Petrov; Olga Zhidkova; Vladimir Serikov; Valery Zenin; Boris Popov
Journal:  Stem Cells Dev       Date:  2011-07-22       Impact factor: 3.272

Review 6.  Modelling mammalian cellular quiescence.

Authors:  Guang Yao
Journal:  Interface Focus       Date:  2014-06-06       Impact factor: 3.906

7.  Inhibition of the cyclin D1/E2F pathway by PCA-4230, a potent repressor of cellular proliferation.

Authors:  D Goukassian; S M Sanz-González; I Pérez-Roger; J Font de Mora; J Ureña; V Andrés
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

8.  Distinct mechanisms for repression of RNA polymerase III transcription by the retinoblastoma tumor suppressor protein.

Authors:  Heather A Hirsch; Gauri W Jawdekar; Kang-Ae Lee; Liping Gu; R William Henry
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium.

Authors:  M R Frey; J A Clark; O Leontieva; J M Uronis; A R Black; J D Black
Journal:  J Cell Biol       Date:  2000-11-13       Impact factor: 10.539

Review 10.  Role of the Holoenzyme PP1-SPN in the Dephosphorylation of the RB Family of Tumor Suppressors During Cell Cycle.

Authors:  Eva M Verdugo-Sivianes; Amancio Carnero
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.